ICM
CGNT icon

Invenomic Capital Management’s Cognyte Software CGNT Stock Holding History

Invenomic Capital Management’s Portfolio CGNT Stock Details CGNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-919,102
Closed -$3.12M – 138
2023
Q1 		$3.12M Buy
919,102
+20,814
+2% +$75K 0.18% 111
2022
Q4 		$2.79M Buy
898,288
+194,071
+28% +$570K 0.19% 113
2022
Q3 		$2.85M Buy
704,217
+169,603
+32% +$804K 0.24% 105
2022
Q2 		$2.27M Buy
534,614
+109,010
+26% +$764K 0.16% 118
2022
Q1 		$4.81M Buy
+425,604
New +$4.92M 0.51% 63

Other funds holding CGNT

EC
Edenbrook Capital Mt. Kisco, New York $321M AUM 79.21% 1-Year Est. Return
ACM
American Capital Management New York $1.86B AUM 20.23% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
WCM
Westerly Capital Management San Francisco, California $368M AUM 42.67% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Invenomic Capital Management's CGNT Position: Q2 2023 in Review

Invenomic Capital Management sold out of Cognyte Software (CGNT) in Q2 2023, closing a stake of 919,102 shares — an estimated $3.12M sold.

Invenomic Capital Management first reported a position in CGNT in Q1 2022 and held it in 5 quarters. The position peaked at $4.81M in Q1 2022. 97 funds tracked by Wall St. Rank hold CGNT as of Q2 2023.

  • Invenomic Capital Management reported no remaining Cognyte Software position as of Q2 2023 after selling out during the quarter.
  • Invenomic Capital Management sold 919,102 Cognyte Software shares in Q2 2023, an estimated $3.12M.
  • Invenomic Capital Management first reported a position in Cognyte Software in Q1 2022 and held it in 5 quarters.
  • Invenomic Capital Management's Cognyte Software position peaked at $4.81M in Q1 2022.
  • 97 funds tracked by Wall St. Rank held Cognyte Software as of Q2 2023.

Based on Invenomic Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.